Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sergio Valente

Showing results (151-160 of 155) with videos related to

Pageof 16
Sort By:
You have reached the last page of results.This site can display upto 155 results.
Science Advances|March 27, 2026
A synergistic interaction between PRMT5 and LSD1 inhibitors in AMLNesteene Joy Param, Elisa Arceci, Francesco Fiorentino, et al.
Gastroenterology|July 10, 2021
Metabolic Rewiring by Loss of Sirt5 Promotes Kras-Induced Pancreatic Cancer ProgressionTuo Hu, Surendra K Shukla, Enza Vernucci, et al.
Oncotarget|June 8, 2018
Multi-omics profiling reveals a distinctive epigenome signature for high-risk acute promyelocytic leukemiaAbhishek A Singh, Francesca Petraglia, Angela Nebbioso, et al.
Oncotarget|June 8, 2018
Combined HAT/EZH2 modulation leads to cancer-selective cell deathFrancesca Petraglia, Abhishek A Singh, Vincenzo Carafa, et al.
Nature Communications|January 6, 2018
Targeting the CoREST complex with dual histone deacetylase and demethylase inhibitorsJay H Kalin, Muzhou Wu, Andrea V Gomez, et al.
Pageof 16

Showing results (151-160 of 155) with videos related to

Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 155 results.
Science Advances|March 27, 2026
A synergistic interaction between PRMT5 and LSD1 inhibitors in AMLNesteene Joy Param, Elisa Arceci, Francesco Fiorentino, et al.
Gastroenterology|July 10, 2021
Metabolic Rewiring by Loss of Sirt5 Promotes Kras-Induced Pancreatic Cancer ProgressionTuo Hu, Surendra K Shukla, Enza Vernucci, et al.
Oncotarget|June 8, 2018
Multi-omics profiling reveals a distinctive epigenome signature for high-risk acute promyelocytic leukemiaAbhishek A Singh, Francesca Petraglia, Angela Nebbioso, et al.
Oncotarget|June 8, 2018
Combined HAT/EZH2 modulation leads to cancer-selective cell deathFrancesca Petraglia, Abhishek A Singh, Vincenzo Carafa, et al.
Nature Communications|January 6, 2018
Targeting the CoREST complex with dual histone deacetylase and demethylase inhibitorsJay H Kalin, Muzhou Wu, Andrea V Gomez, et al.
Pageof 16